<code id='016D0C6ADA'></code><style id='016D0C6ADA'></style>
    • <acronym id='016D0C6ADA'></acronym>
      <center id='016D0C6ADA'><center id='016D0C6ADA'><tfoot id='016D0C6ADA'></tfoot></center><abbr id='016D0C6ADA'><dir id='016D0C6ADA'><tfoot id='016D0C6ADA'></tfoot><noframes id='016D0C6ADA'>

    • <optgroup id='016D0C6ADA'><strike id='016D0C6ADA'><sup id='016D0C6ADA'></sup></strike><code id='016D0C6ADA'></code></optgroup>
        1. <b id='016D0C6ADA'><label id='016D0C6ADA'><select id='016D0C6ADA'><dt id='016D0C6ADA'><span id='016D0C6ADA'></span></dt></select></label></b><u id='016D0C6ADA'></u>
          <i id='016D0C6ADA'><strike id='016D0C6ADA'><tt id='016D0C6ADA'><pre id='016D0C6ADA'></pre></tt></strike></i>

          fashion

          fashion

          author:fashion    Page View:1745
          Daphne Koller -- biotech coverage from STAT
          Daphne Koller, early biotech AI entrant Insitro's founder, CEO and board member. Courtesy Jerrick Mitra/Insitro

          New artificial intelligence technologies made headlines last year for their ability to do everything from generating fake musical duets to understanding how proteins fold. But in biotech, one of the most well-funded AI players has been quiet.

          Insitro, a South San Francisco firm, was founded in 2018 by Daphne Koller, who had previously been a Stanford professor, a 2004 MacArthur “genius” grant recipient, and the co-founder and co-CEO of the online course company Coursera. It raised more than $643 million in venture capital, according to PitchBook, from investors including T. Rowe Price, ARCH Venture Partners, and Casdin Capital. The company now has more than 260 employees spread out over 107,000 square feet of laboratory and office space.

          advertisement

          But what exactly is Koller building?

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more
          FDA approves Eli Lilly ulcerative colitis treatment Omvoh
          FDA approves Eli Lilly ulcerative colitis treatment Omvoh

          DarronCummings/APTheFoodandDrugAdministrationonThursdayapprovedanEliLillydrugthattakesanewapproachto

          read more
          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more

          Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

          CourtesyBristolMyersSquibbWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetour